Penumbra enrolls first patient in stroke thrombectomy study
Go back to Penumbra enrolls first patient in stroke thrombectomy study| (NYSE: PEN) | Delayed: 317.90 +1.40 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $316.50 | 52 Week High | $79.49 | |||
| Open | $315.70 | 52 Week Low | $40.23 | |||
| Day High | $317.95 | P/E | N/A | |||
| Day Low | $315.70 | EPS | $0.00 | |||
| Volume | 690,634 | |||||

